Unproven ideas
Zeile 4: | Zeile 4: | ||
{{tp|p=32311318|t=ä. SARS-CoV-2 and ''viral sepsis'': observations and hypotheses |pdf=|usr=}} | {{tp|p=32311318|t=ä. SARS-CoV-2 and ''viral sepsis'': observations and hypotheses |pdf=|usr=}} | ||
{{tp|p=32325026|t=2020. Endothelial cell infection and endotheliitis in COVID-19 |pdf=|usr=}} | {{tp|p=32325026|t=2020. Endothelial cell infection and endotheliitis in COVID-19 |pdf=|usr=}} | ||
− | |||
{{ttp|p=32205092|t=ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |pdf=|usr=}} | {{ttp|p=32205092|t=ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |pdf=|usr=}} | ||
− | |||
*[https://www.forbes.com/sites/allisongasparini/2020/05/24/new-research-shows-electroceutical-fabric-eradicates-coronavirus-infectivity-on-contact electrostatic repellent tissue filter] | *[https://www.forbes.com/sites/allisongasparini/2020/05/24/new-research-shows-electroceutical-fabric-eradicates-coronavirus-infectivity-on-contact electrostatic repellent tissue filter] | ||
*[https://www.webmd.com/lung/news/20200522/blood-vessels-in-lungs-split-in-response-to-covid19 special pattern of pulmonary neoagiogenesis] | *[https://www.webmd.com/lung/news/20200522/blood-vessels-in-lungs-split-in-response-to-covid19 special pattern of pulmonary neoagiogenesis] | ||
{{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}} | {{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}} | ||
− | |||
{{tp|p=32352407|t=2020. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists |pdf=|usr=}} | {{tp|p=32352407|t=2020. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists |pdf=|usr=}} | ||
{{tp|p=32340759|t=ä. Inappropriate Antibiotic Consumption as a Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | {{tp|p=32340759|t=ä. Inappropriate Antibiotic Consumption as a Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | ||
Zeile 19: | Zeile 16: | ||
*[https://www.metro.news/lockdown-law-bans-sex-if-youre-living-apart/2031854/ Kein Geschlechtsverkehr außerhalb der Ehe...] | *[https://www.metro.news/lockdown-law-bans-sex-if-youre-living-apart/2031854/ Kein Geschlechtsverkehr außerhalb der Ehe...] | ||
*[https://web.de/magazine/panorama/who-warnt-antibiotika-einsatz-covid-19-patienten-34756208 who speaks against antibiotics] | *[https://web.de/magazine/panorama/who-warnt-antibiotika-einsatz-covid-19-patienten-34756208 who speaks against antibiotics] | ||
+ | *[https://www.newsweek.com/russia-developing-coronavirus-treatment-that-disinfects-body-uv-light-inside-1508350 uv emitting particles to be inhaled under dev in Russia] |
Version vom 7. Juni 2020, 20:45 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
32337769 2020. (tt bradykinin) Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2 |
32311318 ä. SARS-CoV-2 and viral sepsis: observations and hypotheses
32325026 2020. Endothelial cell infection and endotheliitis in COVID-19
32205092 ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |
32302401 2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps
32352407 2020. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists
32340759 ä. Inappropriate Antibiotic Consumption as a Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with Coronavirus Disease 2019 (COVID-19)
32359101 2020. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications personally top relevenat bk activates trpm7 mg channel/kinase causing various effects
32338605 2020. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
32065055 2020. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
C7118608 ä. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System